Novavax COVID-19 vaccine receives provisional approval
New Zealand medicines regulator Medsafe has granted provisional approval of the Novavax COVID-19 vaccine, Nuvaxovid, for adults 18 years and over
Stay updated with breaking news from Technical Advisory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New Zealand medicines regulator Medsafe has granted provisional approval of the Novavax COVID-19 vaccine, Nuvaxovid, for adults 18 years and over
This week the Government announced the change in the face of the looming Omicron outbreak, saying it would capture an extra million New Zealanders who were
New Zealand is one step closer to rolling out the Novavax protein-based COVID-19 vaccine called Nuvaxovid, with the ...
New Zealand medicines regulator Medsafe has granted provisional approval of the Novavax COVID-19 vaccine, Nuvaxovid, for adults 18 years and over
People can now get their booster vaccinations three months after their second shot rather than wait for four months, as the Government tries to stay ahead